Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
about
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian IndiansAssociations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.Next-generation gene discovery for variants of large impact on lipid traitsLinkage of familial combined hyperlipidaemia to chromosome 1q21-q23Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismGenomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibshipsCombined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16qA rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotypeGenomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent.Unraveling the complex genetics of familial combined hyperlipidemia.SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province.An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease.Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.The genetics of familial combined hyperlipidaemia.The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.Molecular diagnostics for cardiovascular disease.Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.Study of apolipoproteinc3 Sstl polymorphism in healthy volunteers from Northern India.Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels.Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia.Familial combined hyperlipidemia plasma stimulates protein secretion by HepG2 cells: identification of fibronectin in the differential secretion proteome.Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort.Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids.Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.Triglyceride level-influencing functional variants of the ANGPTL3, CILP2, and TRIB1 loci in ischemic stroke.Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.Apolipoprotein CIII polymorphism and triglyceride levels of a Japanese population living in Southern Brazil.APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals.Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families
P2860
Q21283798-67D08CB7-327E-447A-AF34-B90AB2C6F48FQ25255216-363DE588-CE86-46D9-830C-61A2ED7850BDQ28088415-E8776B2B-3EA6-44BE-BEA9-B2E3CCA1636AQ28267263-11A21B89-105E-4D5E-856F-23F9D13C84CDQ28363810-7B40D15E-2E68-4DC3-96CA-44A36B5D398AQ33689539-B52A9567-8004-42CC-92DF-F94AA3DBC689Q33905086-7F050F23-1407-466B-8623-CE66F86D5713Q34205523-5246B109-7044-44C1-9A97-64612F951F35Q34386695-173B136F-EB89-4BFE-9B1D-EEB5484CE29CQ34389639-B6C613B4-5118-4F5C-A23D-E517D99419E0Q34389958-098E2D6F-0764-4448-9CFC-B732D4CDF4F5Q36441470-E705EDC4-3F4E-4F38-80D6-FF3087F839F7Q36580345-ED99D7E1-623F-43EE-8402-9DC2387898F1Q36652519-907763B4-81D9-42ED-9C2C-E7B0B061BB92Q36745050-8E4EE838-88D1-45E4-B14B-1C71D54B8F7AQ36915226-771E460A-1FA0-4729-9549-D5DC9E78FF36Q37412485-72CCEF03-50DD-4B22-830A-ECF5EA1E723BQ37983699-415F9251-DFAF-482B-9CBC-FDBC23DE7E6BQ39280707-1FD57955-B088-44B1-A7A3-39AE78998185Q40836393-B60DEF82-947F-408F-A650-061784B23D47Q41875837-7561C4B0-6E1B-45F4-B660-F00C5649A153Q42128919-133D8819-1340-489F-9648-3024CE901FFAQ43818021-4C4D9221-FD95-44FD-B829-2F10606F71A8Q43986435-8F1CADF9-04CC-4186-AE25-A4B3A79CDE13Q44063130-E1B0F396-E8A7-4909-9FC2-B022A09FAF58Q44195486-F8F0B5CB-EA0B-43AB-AEBB-9B7E1CF8605AQ44308570-4DC413B3-A927-4DA1-9682-4028864E1F9AQ44387518-5BB84842-6B2A-4553-B0ED-1CF69A6C32F4Q44552183-313BA261-1745-4917-A39F-B22107A22781Q44902860-447D1ADC-1E98-4A23-9BCA-7ED5DF53D920Q45094125-84FF4136-C757-41F1-8144-D0F84287463FQ46534781-8DEE3068-9B31-4C3F-91A9-A975B9E3337EQ46821339-33952CE4-FFE3-4E1E-AF64-ADCA29EB2274Q56982669-F048ED5C-EB5E-42A2-B48A-A7977ACC396B
P2860
Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complex genetic contribution o ...... ent susceptibility haplotypes.
@en
Complex genetic contribution o ...... ent susceptibility haplotypes.
@nl
type
label
Complex genetic contribution o ...... ent susceptibility haplotypes.
@en
Complex genetic contribution o ...... ent susceptibility haplotypes.
@nl
prefLabel
Complex genetic contribution o ...... ent susceptibility haplotypes.
@en
Complex genetic contribution o ...... ent susceptibility haplotypes.
@nl
P2093
P2860
P356
P1476
Complex genetic contribution o ...... ent susceptibility haplotypes.
@en
P2093
G M Dallinga-Thie
J I Rotter
M van Linde-Sibenius Trip
R M Cantor
T W de Bruin
P2860
P304
P356
10.1172/JCI119260
P407
P577
1997-03-01T00:00:00Z